Settlement Proposed in CareDx, Inc. Securities Class Action Case A settlement of $20.25 million has been proposed in the CareDx, Inc. securities litigation. Class members who purchased shares may benefit.

Settlement Proposed in CareDx, Inc. Securities Class Action Case #United_States #Securities #San_Francisco #Settlement #CareDx

Connect with CareDx at #WorldTransplantCongress.

Visit our booth, review new data and abstracts, take a lab tour, and attend the symposium to see how #CareDx is offering a new take on transplant.

Reserve your symposium spot and lab tour today: bit.ly/45YQrKk

#WTC2025

Investigation Continues Into CareDx Officers by Former Louisiana Attorney General's Firm Former Louisiana Attorney General Charles C. Foti, Jr. leads an ongoing investigation into CareDx, Inc., looking into potential misconduct by its executives and directors.

Investigation Continues Into CareDx Officers by Former Louisiana Attorney General's Firm #USA #New_Orleans #Kahn_Swick #Charles_Foti #CareDx

TC BioPharm Collaborates with CareDx for Groundbreaking Clinical Trial in Allogeneic Cell Therapy TC BioPharm has partnered with CareDx to enhance the ACHIEVE clinical trial, focusing on pharmacokinetic analysis of allogeneic cell therapy for AML.

TC BioPharm Collaborates with CareDx for Groundbreaking Clinical Trial in Allogeneic Cell Therapy #United_Kingdom #Edinburgh #TC_BioPharm #Achieve #CareDx